You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis

 

Online download statistics by month:

Online download statistics by month: September 2023 to February 2026

AbstractFullPdf
Sep 2023788794197
Oct 202331231368
Nov 2023284289138
Dec 2023215216177
Jan 2024230231163
Feb 2024180182109
Mar 2024204205146
Apr 2024217217185
May 2024200203136
Jun 2024284288212
Jul 2024204205126
Aug 2024131130111
Sep 2024199203144
Oct 2024214214256
Nov 2024222224163
Dec 2024276284164
Jan 2025212213152
Feb 2025326326216
Mar 2025293294242
Apr 2025318319257
May 2025235236173
Jun 202511011082
Jul 2025110
Aug 2025110
Feb 2026110
Total565756993617